ME Therapeutics Holdings Inc.

DB:Q9T Stock Report

Market Cap: €56.8m

ME Therapeutics Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:Q9T Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Dec 23Sell€3,550Kenneth HarderIndividual6,500€0.55

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of Q9T?
Owner TypeNumber of SharesOwnership Percentage
Private Companies73,3330.31%
General Public11,042,17646.7%
Individual Insiders12,518,92953%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 4 shareholders own 53.28% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.7%
Salim Dhanji
4,175,143€10.0m0%no data
17.7%
John Priatel
4,175,143€10.0m0%no data
17.6%
Kenneth Harder
4,168,643€10.0m0%no data
0.31%
Donaldson Brohman Martin, CPA Inc.
73,333€176.3k0%no data